The Option Is Real, the Price Already Owns It: Initiating Centrus at Hold After a Gross-Loss Quarter and $1B of Announced Dilution

Results vs. Consensus

Centrus reported after the close on November 5 and held its call the following morning, November 6, at 8:30 a.m. ET. That morning, before the call, the company announced a $1B at-the-market equity offering program. The sequencing matters: shareholders processed a missed quarter and a fifth of the equity in shelf form inside the same session.

This is our initiating note on Centrus, so it is worth being explicit about what the company currently is. Management calls one half of it the "broker trader business," which is accurate: Centrus buys enriched uranium and natural uranium, including under a Russian supply contract, and resells it to US utilities under multi-year commitments. The other half is a services segment operating a small demonstration cascade for the Department of Energy. Neither of those is the reason the stock trades where it does. The reason is a proposed enrichment plant at Piketon, Ohio, which does not yet exist, is not yet funded, and has no disclosed capital cost.

Year-over-Year Comparison

Nine-Month Comparison

Segment Performance

Centrus reports two segments. The LEU segment is the resale business and carries the backlog that matters. Technical Solutions is the DOE demonstration work, contracted on a cost-plus-incentive-fee basis, and carries a low margin: an 11.6% gross margin this quarter.

LEU segment

Revenue of $44.8M rose $10.0M, and the composition inverted. Uranium contributed $34.1M against nothing in the year-ago quarter. SWU revenue fell $24.1M, which the company attributes to a 69% decrease in the average price of SWU sold. Cost of sales rose $23.0M to $52.6M, with uranium costs up on volume and SWU costs down on a 41% decrease in the average unit cost of SWU sold. Net of all of that, the segment lost $7.8M at the gross line.

The company's explanation is contract timing, and it is credible. LEU customers hold multi-year contracts with annual rather than quarterly commitments, so quarterly mix swings on which contracts happen to deliver. Management said the point directly on the call.

"As many of you know, there can be a significant amount of variability quarter-to-quarter due to the nature of our business. And as such, we believe our annual results are more indicative of our progress." — Amir Vexler, President and Chief Executive Officer

Assessment: The variability argument is true and it is also a two-way instrument. A business that cannot be judged on a quarter cannot be credited for a good one either, and the nine-month gross margin of 27.3% is the honest number for this year rather than any single quarter's. The harder fact underneath the mix argument is that the average SWU price realized fell 69% in Q3, while the published spot price was climbing toward the $220 near-record print management cited for October. That gap is the whole economic character of the resale business: it earns yesterday's contracted prices, not today's spot. A shareholder buying LEU for the SWU price chart is buying an exposure the current business does not have.

Technical Solutions segment

Revenue of $30.1M rose 31%, driven by a $7.3M increase under the 2022 HALEU Operation Contract with the DOE. Gross profit was $3.5M against $3.7M, essentially flat, and the reason is disclosed: because Phase 2 of that contract was delayed, DOE extended the period of performance through October 31, 2025, and costs incurred after November 2024 have not yet carried a fee because that portion remains undefinitized and subject to negotiation.

Assessment: This segment grew 31% and earned $0.2M less. That is a cost-plus contract running without an agreed fee on part of its scope for close to a year, which means revenue growth here converts to no incremental profit until the negotiation closes. It is a small line in dollars and a useful demonstration in kind: the operating cascade reached two full years of continuous enrichment in October and over 3.9 million machine hours, which is the technical proof point the whole equity case rests on. Judge this segment on the machine hours, not the margin.

Backlog

Assessment: The $3.9B headline is the single most cited number in the bull case and it needs reading in parts. Of the $3.0B LEU figure, $2.3B is contingent on a plant that does not exist and on funding that has not been committed, and $0.2B of that is not even under a definitive agreement yet. The Technical Solutions $0.9B explicitly includes unfunded amounts and unexercised options. What is left as firm, near-term, fully committed revenue is a fraction of the total. That is not a criticism of the disclosure, which is unusually clear about the conditionality. It is a caution against capitalizing $3.9B as though it were a contracted book.

Key Topics & Management Commentary

Overall Management Tone: Confident on the market, deliberately unspecific on economics, and noticeably more forthcoming about capital plans than about costs. The CEO answered market-structure questions in detail and declined, more than once and explicitly, to discuss the SWU price required to underwrite the expansion or the terms under discussion with prospective investors. A new CFO on his first call set his own agenda as capitalizing the balance sheet. The consistent thread across the call is that the funding architecture is being built before the funding decision is known.

1. A $1B at-the-market program, announced the morning of the call

The biggest new item was not in the earnings release. The company filed a shelf registration and simultaneously took down $1B for an at-the-market equity offering, disclosed the morning of November 6.

"Second, this morning, we announced we are launching a $1 billion at-the-market program. Given the market signal and our progress, we believe now it is an appropriate time to raise these funds in this form ahead of our proposed build-out." — Amir Vexler, President and Chief Executive Officer

The CFO framed it as ordinary practice and as opportunistic use of the share price.

"We believe that having a shelf in place is part of good business practices and that using equity to raise capital at this time is a prudent solution given our strong valuation and lower cost of capital associated with it. We will be using the proceeds from the ATM for general corporate purposes." — Todd Tinelli, Chief Financial Officer

Assessment: The logic is defensible and the disclosure is honest, including the part shareholders liked least. Management is saying the stock is expensive enough that equity is the cheap capital, eleven weeks after issuing $805M of notes at a 0% coupon. Both statements can be true, and together they describe a company that has decided to raise everything it can while the window is open. What makes the reaction rational rather than reflexive is the size against the base: $1B of shelf against a $5.1B market capitalization at the reaction close, on top of a diluted share count already 25.9% above the prior-year quarter, with proceeds designated for general corporate purposes rather than a costed project. Our read is that the market did not object to a capital raise. It objected to an open-ended one with no announced use.

2. The SWU price reached $220 and the company did not capture it

Management put real emphasis on the market signal, and the number is striking.

"Last month, the published spot price for LEU SWU soared to $220, near historic levels. The demand for U.S.-owned enrichment capacity has never been stronger." — Amir Vexler, President and Chief Executive Officer

In the third quarter, weeks before that October print, the average price of SWU the company actually sold fell 69% year over year.

Assessment: The release and the call put both facts on the record, and they belong next to each other. The spot price is a statement about the value of future enrichment capacity, which is the option. The realized price is a statement about the contracts signed years ago, which is the business. Confusing the two is the central analytical error available in this name, and it is the error the share price has been making. A record spot SWU price makes the Piketon case better and does nothing for the next four quarters of reported earnings.

3. Demand arithmetic, stated in units

The CEO put a number on the incremental demand he sees, built from two specific announcements.

"The Nuclear Energy Institute recently identified over 8 gigawatts of expected additional generation from the existing fleet, including plant restarts and power upgrades. And recall that Westinghouse recently pledged to build 10 new large reactors in the United States and the federal government recently announced $80 billion investment related to the project. The combination of just these 2 events could equate to a need for an additional roughly 2.5 million SWU per year." — Amir Vexler, President and Chief Executive Officer

A later analyst question referenced the planned 3.5 million SWU per year base-case capacity at Piketon, and management did not dispute the figure.

Assessment: This is the most useful quantification on the call, because it puts the plant and the market on the same axis. Two announcements alone would absorb roughly 71% of the planned base-case capacity. The caveat is that both are announcements rather than fuel contracts, and the timelines for new large reactors run well past the plant's own schedule. Treat 2.5 million SWU as a demand ceiling being sized, not a signed order book.

4. The public half of the funding model is still waiting on Washington

Management laid out the public-private structure plainly: task orders under the LEU enrichment contract or the HALEU enrichment and deconversion contract, together representing a chance at a portion of $3.4B, or a potential national security award. Asked directly whether the government shutdown was delaying distribution, the CEO did not claim knowledge he did not have.

"Officially, I do not know. I honestly have no idea. I suspect maybe the answer is yes, but I don't know anything officially." — Amir Vexler, President and Chief Executive Officer

Assessment: Credit for the answer and note what it means. The lowest-cost capital in the plan, which management says it hopes to capitalize on because it creates the lowest cost of capital structure, is on a timetable the company cannot see and does not control. That is precisely why the ATM exists and why it is sized the way it is. It is also why a shareholder cannot underwrite the equity on the public-funding leg: the amount, the share and the date are all unknown, and the $3.4B is a congressional appropriation of which Centrus can hope to obtain a portion, not an allocation to Centrus.

5. A national security opportunity appeared, unquantified

The first analyst question concerned a National Nuclear Security Administration notice of intent to sole-source an award to American Centrifuge Operating for unobligated LEU enrichment.

"I am not sure that I can add anything beyond what the NNSA announced. It is an intent to a sole-source award... So what I would read into this is that things are moving forward, it looks. It looks like the things that we were aiming for are materializing." — Amir Vexler, President and Chief Executive Officer

Assessment: A notice of intent to sole-source is a meaningful procedural signal and carries no disclosed value, scope or date. Unobligated enrichment, meaning material free of foreign obligations, is a capability only a US-owned enricher can supply, which is the structural argument for why this class of award should land here. It belongs in the option, not the model.

6. Korean partners, and the private half of the model

In August the company signed an agreement with Korea Hydro & Nuclear Power and POSCO International for potential investment supporting the Piketon expansion. Asked about the trade-offs of third-party capital, the CEO was candid about the shape of the negotiation without giving terms.

"Obviously, if an investor invests, they expect something in return. And it's a process of negotiations to ensure that we can find a win-win solution. When you're in an environment where you're hitting record SWU prices and the prospects appear that they will continue to go up... that helps make a very strong case for an investor that comes in." — Amir Vexler, President and Chief Executive Officer

In an earlier answer he said discussions extend beyond the announced parties, including hyperscalers, with nothing ready to name.

Assessment: The strategic logic is sound: a Korean utility operator and a trading house bring both capital and offtake credibility, and the counterparty set described, foreign utilities through small-modular-reactor developers to data-centre owners, is genuinely wide. What is absent is any number. No investment size, no structure, no timeline, no exclusivity. A memorandum of understanding for a potential investment is worth exactly as much as the definitive agreement it may become.

7. The CFO's stated priority is the balance sheet, not the income statement

Todd Tinelli, who succeeded Kevin Harrill, framed his own remit on his first call.

"Looking ahead, I will be focused on appropriately position our balance sheet and potential partnership network to sufficiently capitalize the company for our future needs and implementing best practices across our operations to support our potentially large expansion." — Todd Tinelli, Chief Financial Officer

He also disclosed that excluding non-recurring costs associated with the CFO transition, third-quarter net income was $4.6M against the reported $3.9M.

Assessment: The hire reads as fit-for-purpose: twenty years in energy, experience of large industrial expansions and capital raises, which the CEO called "precisely and not coincidentally the tasks we're facing now." That candour about what the job is tells you what the next two years look like. It also tells you that the CFO's success metric is access to capital rather than earnings, which is the right priority for the company and a real signal for anyone modelling per-share anything.

8. Asked what price makes the expansion work, management declined

The most important unanswered question on the call was about the economics of the plant itself.

"To your question about SWU pricing and what is an advantageous or hurdle SWU pricing, obviously, I will not be able to name that because that will point to our cost structure and things that we normally would not want anybody to know. It's very proprietary and sensitive information to us. But I will say to you, though, that the SWU pricing that we're seeing right now is not bad." — Amir Vexler, President and Chief Executive Officer

Assessment: The refusal is commercially reasonable and analytically disabling. Without a hurdle price, a capital cost, or a capacity ramp schedule, the plant cannot be valued by any method other than assertion. "Not bad" at a $220 spot print is a floor observation, not an economics disclosure. Until Centrus publishes a capital cost and a target unit cost for Piketon, the difference between a bull and a bear on this name is temperament rather than arithmetic. That, more than the quarter, is why we initiate at Hold.

9. The 2028 Russian import cliff is unmoved

The company secured DOE waivers to import LEU for all currently committed 2026 and 2027 deliveries, which management fairly described as de-risking. Asked whether Washington's tone on the January 1, 2028 prohibition had softened, the CEO said he knew of nothing he could report.

"There's nothing really that I know that I can report officially or unofficially that I've heard about reconsidering anything has to do with Russia. If you remember, that was done legislatively, and that was tied to an investment here in the U.S. to establish domestic supply chain, which is exciting news." — Amir Vexler, President and Chief Executive Officer

Pressed on what the business looks like in 2028 through 2030 if the deadline holds, he declined to speculate beyond expecting an extremely tight market.

Assessment: This is the most concrete risk in the name and it has a date. The resale business relies in part on Russian supply under the TENEX contract; waivers now cover 2026 and 2027; the statutory ban resumes for 2028. Piketon is not scheduled to fill that gap on any published timeline. Management's answer, that these will be tight years and it has put a question mark on them too, is honest and is also the admission that a revenue discontinuity sits inside the standard valuation horizon with nothing disclosed to bridge it.

10. HALEU is moving from memoranda to commitments

Asked whether the LEU-versus-HALEU mix had shifted, the CEO described a change in the character of customer conversations rather than in the plan.

"During my time in the company, which is almost 2 years now, particularly in the last year, we have seen HALEU going from sort of like an MOU type, let's agree to some point in the future where we can talk about a contract, very noncommittal to we're seeing companies now, hey, we're ready to make a commitment type conversations." — Amir Vexler, President and Chief Executive Officer

He was explicit that the eventual LEU and HALEU split at Piketon will be entirely customer-driven.

Assessment: A shift from memoranda toward commitments is the right leading indicator and the only one available, since no HALEU contract value has been disclosed. It also carries an underappreciated implication: leaving the mix to customer commitments means the plant's product configuration, and therefore its capital cost and margin profile, is not yet fixed. Optionality for the company is indeterminacy for the modeller.

11. Readiness spending is real and running ahead of the decision

The company is hiring at scale in Ohio, has launched production cycle-time and first-article manufacturing studies, and continues the supply-chain readiness program begun the prior November.

"We are launching things like studies of our production cycle time analysis, first time -- first article manufacturing, things of the sorts that you would need to have lined up for rapid manufacturing deployment, all in anticipation of a planned build-out." — Amir Vexler, President and Chief Executive Officer

Nine-month capital expenditure was $10.1M against $3.4M a year ago.

Assessment: Spending ahead of an award is the correct call if the award comes, and it is the definition of a bet if it does not. The encouraging detail is how small the number still is: $10.1M of nine-month capital expenditure is a rounding error against a $1.6B cash balance, so the readiness program has not yet committed the company to anything it cannot stop. The moment that changes, and the first hard capital number appears, is the moment this equity becomes analysable. It has not arrived.

Guidance & Outlook

Centrus gives no revenue, earnings or margin guidance, and gave none here. The forward-looking content of the release and call is therefore capital structure and contract status rather than numbers. The table below records what was actually put on the record.

What a modeller can actually use: very little on the income statement and a great deal on the balance sheet. The absence of guidance is not evasion here, it is a fair reflection of a business whose quarterly revenue is set by which multi-year contracts happen to deliver. The practical consequence is that consensus for this name is built on contract-timing guesses, which is why a $0.36 estimate can miss by 47% on a $5.5M revenue shortfall. Anyone underwriting LEU on next-year earnings is underwriting a schedule they cannot see.

Street at: pre-print consensus was $0.36 of EPS on $80.4M of revenue from two independent sources in agreement. On November 6, one Outperform target was cut from $452 to $390 with the rating held. A target can fall 14% without the rating moving because the asset being valued has no disclosed capital cost.

Analyst Q&A Highlights

The national security award and what it means for Centrus

The first question of the call went straight to the newest and least quantified opportunity, a sole-source notice for unobligated enrichment.

Q: "Amir, you mentioned the national security opportunity. We saw the BWXT award in September. And then a few weeks later on SAM, the NNSA's notice of intent sole-source contract with ACO for unobligated LEU enrichment. Could you just talk a little bit about Centrus' opportunity there and what that entails?"
— Ryan Pfingst, B. Riley Securities

A: "I am not sure that I can add anything beyond what the NNSA announced. It is an intent to a sole-source award. But I will add just color maybe to it from my perspective in that if you recall, we have repeatedly stated that our strategy is to serve 3 market segments that are important and all 3 of them are growing, the LEU existing market, [HALEU] market and obviously, the national security market."
— Amir Vexler, President and Chief Executive Officer

Assessment: The answer is procedurally correct and commercially empty, which is the right handling of a pending procurement. The substance worth extracting is the three-market framing, because it is the reason the company can argue for public capital at all. National security enrichment is the one segment where being US-owned is not a preference but a requirement, and it is therefore the segment where Centrus faces the least competition and has the least disclosure.

Readiness at Piketon and the next twelve months of decision gates

An analyst asked what has to happen, and when, for the build-out to proceed.

Q: "I just wanted to get if you get a little more color on your readiness efforts at Piketon. How do you sort of foresee that playing out? And what are the decision gates you're looking at in the next sort of 12 months?"
— Robert Brown, Lake Street Capital Markets

A: "The readiness efforts for a plant build-out are taking shape, and they're taking shape fast. We have already announced investment, which we're in the middle of spending as part of that preparedness... So yes, there's a few more things that need to fall into place in terms of the public part of it."
— Amir Vexler, President and Chief Executive Officer

Assessment: The question asked for decision gates and did not get any. What came back was an account of preparation plus an acknowledgement that the public leg still has to fall into place. That is the honest state of play and it is also the reason no dated milestone exists for a shareholder to hold management to. The absence of a gate calendar is the single largest difference between this equity and an ordinary project-finance story.

The 2028 Russian import deadline and the years after it

The most consequential risk question of the call asked what the business looks like if the statutory ban holds.

Q: "Now that you guys have the waivers for '26 and '27, and there's been these extra announcements about investments in nuclear facilities restarts and new facilities. Has there been any shift in political commentary out of Washington about the Jan 1, 2028 deadline for Russian imports? Any realization that's an unreasonable date? And then if not, what do you guys -- how do you guys think about the late 2020s and early 2030s as far as a the business model until you guys ramp up production?"
— Joseph Reagor, ROTH Capital

A: "You're asking me to speculate. I would not be able to answer that. I do think -- I do believe that there is going to be an extremely tight market in the years that you're mentioning for the reasons that I mentioned earlier is that a lot of stuff is coming online. Russia has been really banned out. So these are going to be tight years. We're going to work as hard as we can to make sure there's enough capacity. But these are the years that I've put a question mark on as well."
— Amir Vexler, President and Chief Executive Officer

Assessment: The last sentence is the most valuable admission on the call. The chief executive of the company has a question mark over 2028 through 2030, which is the middle of any reasonable discounted horizon for this equity. A tight market is good for a producer with capacity and hostile to a reseller whose supply has been legislated away. Centrus is currently the second of those and is trying to become the first.

Whether $220 per SWU is already a depressed price

An analyst pushed on market structure, suggesting Russian volumes may be holding the price down relative to where a genuinely tight market would clear.

Q: "We saw kind of a pretty significant uptick in SWU prices during the quarter, up to $220 per SWU. So just could we kind of parse out kind of the dynamics that we're seeing? Because obviously, Russia is kind of, for lack of a better term, rushing to kind of get their fair share of the U.S. market and so supplying SWU on the market. So if we kind of peel back the onion a little bit, is that could we argue that, that's almost even a depressed kind of price at $220 and where that can be going?"
— Nicholas Amicucci, Evercore ISI

A: "My personal view on things is, as I always mentioned, the only way the price is going to go down is when there is excess capacity in the market. I do not see a line of sight to that based on what we're seeing, we're seeing the demand side of the equation growing so much faster than any new capacity coming online, at least announced new capacity... And really all it takes is indication of Western capacity inability to meet that demand. And I think you will see that the prices take a much sharper turn than we've seen before."
— Amir Vexler, President and Chief Executive Officer

Assessment: The supply-side reasoning is straightforward and hard to argue with: enrichment capacity takes years to build, announced Western additions trail demand growth in management's view, and demand announcements are accumulating monthly. The bear response is not that the analysis is wrong but that it is consensus, priced into a stock up 389% year to date, and unavailable to the current business because realized SWU prices are contracted years in advance. A sharper turn in spot enriches the option and not the earnings.

Why private capital has not already arrived at scale

The sharpest question of the call asked why data-centre owners committing gigawatts to nuclear are not already funding fuel supply.

Q: "It seems like there's -- this is not a technology risk issue. It's really just one of capital and capital is going to determine what the cost basis looks like. Could you maybe just discuss any nongovernment private sector discussions that you guys might be engaged in?... I just find it hard to believe that the trillions of CapEx being deployed, many of which I can think of one data center in particular, that has at least 7 gigawatts of their capacity tied to nuclear that they're not aware of the supply chain gap in terms of fueling."
— Jonathan Dorsheimer, William Blair

A: "We do have discussions with numerous parties. We've already publicly announced the KHNP and POSCO, but we also have discussions with other interested parties like hyperscalers. We're not at the point of announcing anything or naming anybody, but I will, though, put some energy behind what you said. We are seeing very encouraging signs out there that people now are turning their attention to fuel, and they realize that investment has to be -- it has to be made in the fuel."
— Amir Vexler, President and Chief Executive Officer

Assessment: The framing in the question is the correct one and the answer confirms it: this is a financing problem, not a technology problem, and the company's technology has 3.9 million machine hours behind it. What the answer does not explain is the gap between stated hyperscaler interest and executed commitments. One memorandum of understanding is a thin conversion rate against the described level of interest. Until a second named counterparty signs something definitive, the private leg of the public-private model is a claim rather than a plan.

What signal would trigger expansion beyond 3.5 million SWU

An analyst asked both halves of the economics question: what triggers a doubling, and what price underwrites it.

Q: "I was wondering what signals would you look for to announce further expansion beyond the planned 3.5 million SWU capacity, perhaps doubling it? And how much time it will take to get there? And then finally, it seems you have a bullish view on SWU pricing. I was wondering what SWU pricing is required to incentivize more expansions? And what SWU pricing are you underwriting in your own expansion?"
— Vikram Bagri, Citi

A: "There is a large population out there that is perhaps sitting it out for now and waiting to see how things progress and how we will execute... So I fully expect that once planned execution is underway, we're going to get more interest and more commitment for further expansion... obviously, I will not be able to name that because that will point to our cost structure and things that we normally would not want anybody to know."
— Amir Vexler, President and Chief Executive Officer

Assessment: The first half of the answer is a real and slightly uncomfortable disclosure: a large part of the potential customer base is waiting to see execution before committing, which means the commitments arrive after the capital, not before it. That is the ordinary sequencing of a first-of-a-kind industrial project and it is exactly what makes the equity risky at this price. The second half is a declined answer to the only question that would let anyone value the plant.

Whether strategic investors are waiting for the government

A question aimed at the interlock between the public and private legs drew the new CFO's clearest statement of intent.

Q: "I was curious, are strategic investors looking for you to further derisk the balance sheet yourself before committing to funding? Or are they perhaps waiting for the government or national security type funding to come through before those conversations progress further?"
— Unknown Analyst, on for Bill Peterson, JPMorgan

A: "One of the things that is our objective is to put us in a position that really we're not reliant on one source of capital to come in to fund our proposed or planned expansion. So obviously, when we're looking at private investments that come in, there is offtake arrangements. There's a variety of different scenarios that could take place. But our first objective is to well capitalize the balance sheet and have a capital structure that allows Centrus to be well positioned for the future."
— Todd Tinelli, Chief Financial Officer

Assessment: This is the answer that explains the same morning's $1B shelf. Management's stated objective is independence from any single capital source, which in practice means raising equity now so that neither the DOE's timetable nor a strategic investor's terms can dictate outcomes. Strategically sensible, and for existing holders it converts an uncertain future dilution into an authorized present one. The question of whether investors are waiting for the government was not answered.

The mix between LEU and HALEU

An analyst asked whether advanced-reactor progress has changed the intended product split at Piketon.

Q: "So have your views on your targeted enrichment mix between LEU and HALEU in the market changed at all given the progress being made by some of the advanced reactor developers? Do you see more robust HALEU demand in the near term becoming more realistic in your view?"
— Unknown Analyst, on for Eric Stine, Craig-Hallum Capital Group

A: "The ultimate decision of the planned expansion in terms of how much HALEU, how much LEU would be 100% driven by customer demand and customer commitments... we have seen HALEU going from sort of like an MOU type... very noncommittal to we're seeing companies now, hey, we're ready to make a commitment type conversations. So we're seeing HALEU evolve very quickly and rapidly, especially through some of these expansion plans that you're hearing from microreactors and other small modular reactors."
— Amir Vexler, President and Chief Executive Officer

Assessment: A demand-led product decision is the right commercial posture and it defers the one input a capital-cost estimate needs most. HALEU and LEU cascades are not interchangeable in configuration or in unit economics, so a plant whose mix is undetermined has a capital cost that is undetermined too. The improvement in the character of HALEU conversations is the genuinely new information and it is qualitative.

Whether higher SWU prices are being contracted into backlog

The final question tried to date the arrival of today's prices in tomorrow's revenue.

Q: "I just have one question on the improved SWU pricing environment. Are you able to contract these? Like has the backlog increased from the new SWU prices? And when should we see -- I know these are longer term -- mid- to long-term contracts, so we may not see it in revenues soon. But when if you have signed contracts, when should we see those prices?"
— Sameer Joshi, H.C. Wainwright

A: "I want to reassure our investors and shareholders that locking in commitments and growing that commitment backlog is a big priority for us... Obviously, we don't disclose details around our contracts. And I will point out to you, though, that a lot of these conversations and the results of these conversations are very nonlinear. So we could be working on something for a while and release something large and then not hear anything or see anything for a little while."
— Amir Vexler, President and Chief Executive Officer

Assessment: The question is the one every holder should be asking and it was not answered. Whether record spot prices are being written into the backlog, and when they would appear in revenue, determines whether the SWU chart is an earnings driver or wallpaper. "Nonlinear" is a fair description of lumpy contracting and it is also an argument for why no shareholder can forecast the conversion. Note the asymmetry the quarter just demonstrated: realized SWU prices fell 69% while spot rose to near-record levels, so the backlog's average vintage is currently working against the company.

What They're NOT Saying

1. The capital cost of the Piketon expansion. Neither the release nor the call contains a dollar figure, a range, or a per-SWU capital intensity for the plant that constitutes most of the equity value. An analyst referenced the planned 3.5 million SWU per year base case in Q&A; the cost of building it was not discussed.
2. The hurdle SWU price. Explicitly declined as proprietary. Without it, no one outside the company can test whether $220 spot clears the project's return threshold, and management's "not bad" is the only guidance available.
3. Any decision-gate calendar. Asked directly what gates the next twelve months hold, management described preparation activity and said a few more things need to fall into place on the public side. No dated milestone was given for a task order, a definitive investment agreement, or a construction decision.
4. What the $1B of at-the-market proceeds will fund. The stated use is general corporate purposes. There is no allocation to Piketon, no minimum price, no expected pace of issuance, and no indication of how the program interacts with the $805M of notes issued eleven weeks earlier.
5. The realized SWU price, in dollars. The release discloses a 69% year-over-year decline in the average price of SWU sold and a 41% decline in average unit cost, both as percentages only. The absolute level is the number needed to compare the book against $220 spot, and it is not given in either document.
6. The size or structure of the KHNP and POSCO investment. Three months after signing, there is no amount, no instrument, no ownership implication and no closing condition.
7. The unresolved HALEU Phase 2 fee. The release states that costs incurred after November 2024 have not yet been subject to a fee because that scope remains undefinitized. The amount of cost carrying no fee, and the fee at issue, are not quantified in either the release or the call, and no analyst asked.
8. How 2028 gets supplied. Waivers cover committed 2026 and 2027 deliveries. For 2028, when the statutory prohibition resumes and Piketon is not scheduled to be at scale, management said it knew of no reconsideration it could report and declined to describe the business model, calling it speculation.
9. The timing of uranium sales. A $34.1M uranium line appeared against nothing in the prior-year quarter and supplied the entire revenue increase. Uranium sales are not new, since nine-month 2024 carried $29.9M, but nothing in the release or the call says what drove this quarter's sale or when the next one lands, which makes the 30% growth rate uninterpretable going forward.
10. The tax benefit. An $11.9M benefit on an $8.0M pre-tax loss is what turned the quarter positive, against a $0.9M benefit a year earlier. Neither document explains the driver, and no analyst asked about the item that produced the reported profit.
11. Concentration. The forward-looking section states that revenue is largely dependent on the largest customers, and neither the release nor the call gives a customer count, a top-customer share, or any concentration figure for a book described as $3.9B.

Market Reaction

• Pre-print setup: LEU closed at $325.73 on November 5, up 389.0% year to date from $66.61 against the S&P 500's +15.6%, and up 330.1% over the trailing twelve months. The stock had cooled into the print, down 8.6% over the trailing thirty days from $356.28. The 52-week closing range entering the print was $54.43 to $436.00.
• Reaction session: the stock opened at $287.35 on November 6, 11.8% below the prior close, traded a range of $266.00 to $299.90, and closed at $277.78, down 14.7% or $47.95.
• Intraday pattern: the low of $266.00 marked an 18.3% decline and the high of $299.90 a 7.9% decline, so the entire session traded below the prior close and the stock finished nearer the low than the high of a 12.7% intraday range.
• Volume: 2.5M shares against a 30-day average of 1.6M, or 1.6x normal.
• Market context: the S&P 500 fell 1.1% on the session, so roughly 13.6 points of the 14.7% decline was idiosyncratic.

The shape is a gap down that never recovered. The 11.8% opening gap priced two items at once: the miss, released the prior evening, and the ATM, announced that morning. The stock then lost further ground through the session. A stock that spends the entire day below the prior close and finishes in the lower half of a wide range has not found a marginal buyer; the 1.6x volume multiple says it did not need to find many sellers either, which is what a decline in a name with a concentrated, conviction-held float looks like.

Both items were public before the open, so the tape cannot separate them. Our read is that the ATM was the larger new fact. The missed quarter was a contract-timing outcome in a business management had already told the market is lumpy, and the nine-month figures were strong. The $1B shelf was not in the earnings release, came eleven weeks after an $805M note issue, carried no stated use of proceeds, and equals roughly a fifth of the market capitalization at the reaction close.

Some perspective on the base: the stock entered the print up 389% year to date and closed the reaction session up 317% year to date, still 410% above the 52-week closing low. A 14.7% single-day decline in a name that has quadrupled is a re-pricing of the funding path, not a re-pricing of the thesis. That is also why we do not read the drop as an entry signal.

Street Perspective

Debate: Is the $3.9B backlog an asset or an aspiration?

Bull view: The bull case holds that a $3.9B book extending to 2040, against a business currently doing roughly $300M of nine-month revenue, is thirteen years of visibility that almost no small-capitalization industrial can match. Of the contingent portion, $2.1B is already under definitive agreements, meaning customers have signed for output from a plant that does not exist, which is the strongest possible validation of demand and the reason public capital should follow.

Bear view: The bear camp responds that $2.3B of the $3.0B LEU backlog is contingent on securing substantial public and private investment, that $0.2B of that is not even under a definitive agreement, and that the $0.9B Technical Solutions figure explicitly includes unfunded amounts and unexercised options. The firm, funded, near-term book is a small fraction of the headline, and the headline is what gets quoted.

Our take: The bears are closer on the accounting and the bulls are closer on what it signifies. Contingent commitments cannot be discounted like contracted revenue and should not be capitalized in a model. They are, however, real evidence that utilities will sign for domestic enrichment before it exists, which is the fact the entire public-private structure depends on. Read the $3.9B as a demand proof and the roughly $1.6B of non-contingent balance as the book.

Debate: Was the ATM prudent or opportunistic dilution?

Bull view: The optimistic reading is that raising equity at a share price up 389% year to date, in a name whose next capital need is a multi-billion-dollar plant, is textbook capital allocation. The alternative is to wait for a DOE decision on a timetable the company cannot see and negotiate strategic capital from weakness. A shelf costs nothing until drawn and buys independence from any single funding source, which is exactly what the CFO said the objective was.

Bear view: The skeptical reading is that a company which raised $805M eleven weeks ago and holds $1.63B of cash does not need $1B more for general corporate purposes, and that announcing it the morning of the call, with no allocation and no floor, treated shareholders as the residual claimant on a funding plan they cannot inspect. Diluted shares are already up 25.9% year over year before the program issues a single share.

Our take: The bulls have the better strategy and the bears have the better grievance. Issuing equity into strength is right, and the intent to be independent of any single capital source is right. The execution invited the reaction: no stated use, no pace, no floor, immediately after a large convertible issue, on the morning of the call. The market did not misread it. Management gave it nothing to read.

Debate: Does a record SWU spot price help the current business?

Bull view: The bull argument is that $220 per SWU near historic highs, with announced Western capacity additions trailing demand growth and demand announcements accumulating monthly, sets the economics for every ton Piketon will ever sell, and that the company is signing into a rising market whose backlog will reprice over time. Management's supply-side logic, that prices fall only when there is excess capacity and no line of sight to any exists, is difficult to refute.

Bear view: The bear response is arithmetic from this quarter's own release. The average price of SWU sold fell 69% year over year in Q3, as spot climbed toward the $220 it reached in October, because the resale business earns prices contracted years ago. Whether current prices are entering the backlog was asked directly and not answered.

Our take: The bears win this quarter and the bulls win the decade, and the distinction is the most important one in the name. A record spot price raises the value of future capacity and does nothing for the next several years of reported results, which will be set by contract vintage. Anyone holding LEU because the SWU chart is rising should be able to state which of those two exposures they own. This quarter says it is not the first one.

Model Update Needed

This is an initiating note, so the table records the starting assumptions rather than revisions.

Valuation: At the $277.78 reaction close on 18,212,032 shares of Class A and Class B common stock outstanding at September 30, the equity is worth roughly $5.06B. Netting approximately $458M of net cash gives an enterprise value near $4.60B. Against nine-month revenue of $302.5M that is roughly 11.4x an annualized run rate, and against the $3.9B headline backlog it is about 1.2x, or roughly 2.9x the non-contingent portion. There is no earnings multiple worth quoting: the business lost $16.6M at the operating line this quarter and reported a profit only after tax and interest income.

We initiate with a fair value range of $240 to $300, a midpoint of $270 that implies (2.8)% from the reaction close. The range is deliberately wide because the asset being valued has no disclosed capital cost. The low end approximates the current business plus net cash with the enrichment option written down toward the roughly 1x-backlog mark; the high end capitalizes a funded, on-schedule Piketon at a premium to backlog without assuming any expansion beyond the 3.5 million SWU base case. A disclosed capital cost, a definitive strategic investment, or a DOE task order would each justify moving the range rather than the rating.

Thesis Scorecard Post-Earnings

We establish the thesis of record with this note. Statuses below are the initiating grades.

Overall: The strategic case is stronger than the financial case by a wide margin, and the gap between them is the investment question. Centrus owns a genuine and probably underappreciated national asset: the only US-owned enrichment technology with years of continuous operation behind it, at the exact moment Western enrichment capacity is short and legislation has removed the largest supplier. That is worth a premium. What it is not yet worth is a number, because the three inputs required to compute one, capital cost, hurdle price and funding date, are all undisclosed, and the one funding data point delivered this quarter was a $1B equity shelf with no stated use.

Action: Initiating at Hold with a fair value range of $240 to $300. We would upgrade on any one of three disclosures: a costed Piketon plan with a target unit cost, a definitive strategic investment agreement with a named amount, or a DOE task order of material size. We would downgrade if at-the-market issuance proceeds materially ahead of any of those, or if the 2028 supply gap approaches with no bridge disclosed. The next print is the fourth quarter and the annual figures, which management has told us is the frame it prefers to be judged on. We will hold it to that.